Nestle raises stake in food allergy drug developer Aimmune

The health science arm of Nestle SA will pay $98 million to raise its stake in Aimmune Therapeutics, as the drug developer prepares to submit a marketing application for its peanut allergy treatment by the end of the year.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news